Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 0.6290
+0.0090 (1.45%)
Sep 24, 2026, 5:29 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 82.79 million as of September 24, 2026. Its market cap has decreased by -81.21% in one year.
Market Cap
82.79M
Enterprise Value
45.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.63
ChartMarket Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 82.79M, a decrease of -85.28%. That is a compound annual growth rate of -22.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 82.79M | -79.70% |
| Dec 30, 2025 | 407.88M | 45.35% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 127.91M |
| Active Biotech AB | 108.47M |
| Nanologica AB | 102.58M |
| Biovica International AB | 91.37M |
| Alzinova AB | 83.99M |
| Pila Pharma AB | 79.49M |
| Spago Nanomedical AB | 75.85M |
| Annexin Pharmaceuticals AB | 65.65M |